FibroGen sells its China unit to AstraZeneca for $160 million, extending its cash runway into 2027 and advancing its ...

Taylor Swift’s, Sabrina Carpenter’s and Jennifer Lopez’s novel takes on Old Hollywood glamour at the Grammy awards encapsulated the experimentation that the Pantone Fashion Color Trend Report delivers ...

People are applying Pantone's 2025 Color of the Year to various parts of their home design, and one great way is through ...

AstraZeneca announces a $570 million investment in Canada, adding 700 jobs and supporting its goal of $80 billion in revenue by 2030. AstraZeneca's Canadian investments since 2023 exceed CA$1.3 ...

AstraZeneca (NASDAQ:AZN) is one of the biggest players in the healthcare sector, whose medicines save the lives of tens of thousands of people every year. In this article, I will share six reasons ...

700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies MISSISSAUGA, ON, Jan. 23, 2025 /CNW ...

MANILA, Philippines — Trade Secretary Cristina Roque reported on Saturday that the British-Swedish pharmaceutical AstraZeneca expressed interest in conducting most of its clinical trials in the ...

AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities investigate the company’s former China head. AZ has received a notice ...

AstraZeneca plc, headquartered in London, UK, is one of the largest biopharmaceutical companies in the world. AstraZeneca was formed on Apr 6, 1999, through the merger of Sweden’s Astra AB and ...

Haematologist Dr Sue Pavord was one of the jab’s biggest supporters, but she knew something was wrong when she saw the side-effects up close When Oxford University developed the AstraZeneca ...

Global biopharmaceutical business AstraZeneca will expand its research and development facilities in Mississauga and relocate its Canadian headquarters to a larger, state-of-the-art office. The $820 ...

The positive recommendation from NICE for osimertinib was based on results from the ADAURA Phase III trial. In which, adjuvant treatment (after surgery) with osimertinib in patients with stage II ...